This slide have the information about chemotherapy:- the treatment of disease by means of chemicals that have a specific toxic effect upon the disease-producing microorganisms or that selectively destroy cancerous tissue.Also include the drug resistance:-Drug resistance is the reduction in effectiveness of a drug such as an antimicrobial.
Immunosuppressants are drugs or medicines that lower the body's ability to reject a transplanted organ. Another term for these drugs is anti-rejection drugs. There are 2 types of immunosuppressants:
Induction drugs: Powerful antirejection medicine used at the time of transplant
Maintenance drugs: Antirejection medications used for the long term.
Immunosuppressants are drugs or medicines that lower the body's ability to reject a transplanted organ. Another term for these drugs is anti-rejection drugs. There are 2 types of immunosuppressants:
Induction drugs: Powerful antirejection medicine used at the time of transplant
Maintenance drugs: Antirejection medications used for the long term.
Definition
History
Chemistry
Properties
Classification & its Generation
Pharmacokinetics
Mechanism of action
Indication
Contraindication
Therapeutic use
Adverse effect
Resistance
Comparison with penicillin
Market preparation
This ppt deals with the sulfonamide group of drugs with classification, mechanism, spectrum, resistance, uses and adverse effects discussed in detail. It also discusses in detail about Cotrimoxazole
Antiprotozoal agents is a class of pharmaceuticals used in treatment of protozoan infection. Protozoans have little in common with each other and so agents effective against one pathogen may not be effective against another
Basic principles of chemotherapy/ AMAs covers definition, history of AMAs development, principles of AMAs, problems associated with AMAs, failure of therapy with examples.
Pharmacology of Penicllins (Beta lactam antibiotics), description of their mechanism of action, mechanism of resistance, classification, indications and adverse effects
Anticancer Drug, also called Anti-Neoplastic drug, that is effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include Alkylating Agents, Anti-metabolites, Plant Alkaloids and Hormones.
Tetracyclines slide contains full information about uses, adverse effect, marketed preparation, precaution, route of drug administration, antimicrobial spectrum, mechanism of action, pharmacokineticks and pharmacodynamics of tetracyclines. This slide is very helpful for pharmacy and pharmacology student for the study about tetracyclines.
Tuberculosis treatment refers to the medical treatment of the infectious disease tuberculosis (TB).
The standard "short" course treatment for TB is isoniazid (along with pyridoxal phosphate to obviate peripheral neuropathy caused by isoniazid), rifampicin (also known as rifampin in the United States), pyrazinamide, and ethambutol for two months, then isoniazid and rifampicin alone for a further four months. The patient is considered to be free of living bacteria after six months (although there is still a relapse rate of up to 7%). For latent tuberculosis, the standard treatment is six to nine months of daily isoniazid alone or three months of weekly (12 doses total) of isoniazid/rifapentine combination. If the organism is known to be fully sensitive, then treatment is with isoniazid, rifampicin, and pyrazinamide for two months, followed by isoniazid and rifampicin for four months. Ethambutol need not be used.
Immunosuppressant are drugs or medicines that lower the body's ability to reject a transplanted organ. Another term for these drugs is anti-rejection drugs. There are 2 types of immunosuppressants: Induction drugs: Powerful antirejection medicine used at the time of transplant.
Definition
History
Chemistry
Properties
Classification & its Generation
Pharmacokinetics
Mechanism of action
Indication
Contraindication
Therapeutic use
Adverse effect
Resistance
Comparison with penicillin
Market preparation
This ppt deals with the sulfonamide group of drugs with classification, mechanism, spectrum, resistance, uses and adverse effects discussed in detail. It also discusses in detail about Cotrimoxazole
Antiprotozoal agents is a class of pharmaceuticals used in treatment of protozoan infection. Protozoans have little in common with each other and so agents effective against one pathogen may not be effective against another
Basic principles of chemotherapy/ AMAs covers definition, history of AMAs development, principles of AMAs, problems associated with AMAs, failure of therapy with examples.
Pharmacology of Penicllins (Beta lactam antibiotics), description of their mechanism of action, mechanism of resistance, classification, indications and adverse effects
Anticancer Drug, also called Anti-Neoplastic drug, that is effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include Alkylating Agents, Anti-metabolites, Plant Alkaloids and Hormones.
Tetracyclines slide contains full information about uses, adverse effect, marketed preparation, precaution, route of drug administration, antimicrobial spectrum, mechanism of action, pharmacokineticks and pharmacodynamics of tetracyclines. This slide is very helpful for pharmacy and pharmacology student for the study about tetracyclines.
Tuberculosis treatment refers to the medical treatment of the infectious disease tuberculosis (TB).
The standard "short" course treatment for TB is isoniazid (along with pyridoxal phosphate to obviate peripheral neuropathy caused by isoniazid), rifampicin (also known as rifampin in the United States), pyrazinamide, and ethambutol for two months, then isoniazid and rifampicin alone for a further four months. The patient is considered to be free of living bacteria after six months (although there is still a relapse rate of up to 7%). For latent tuberculosis, the standard treatment is six to nine months of daily isoniazid alone or three months of weekly (12 doses total) of isoniazid/rifapentine combination. If the organism is known to be fully sensitive, then treatment is with isoniazid, rifampicin, and pyrazinamide for two months, followed by isoniazid and rifampicin for four months. Ethambutol need not be used.
Immunosuppressant are drugs or medicines that lower the body's ability to reject a transplanted organ. Another term for these drugs is anti-rejection drugs. There are 2 types of immunosuppressants: Induction drugs: Powerful antirejection medicine used at the time of transplant.
The quinolones are a family of synthetic broad-spectrum antibacterial drugs. Quinolones, and derivatives, have also been isolated from natural sources and can act as natural antimicrobials and/or signalling molecules.
Antifolates are drugs that antagonise (that is, block) the actions of folic acid (vitamin B9). Folic acid's primary function in the body is as a cofactor to various methyltransferases involved in serine, methionine, thymidine and purine biosynthesis.
The most common mode of action for antibiotics is the inhibition of cell wall synthesis. Antibiotics that inhibit cell wall synthesis work because of the fact that most eubacteria have peptidoglycan-based cell walls but mammals do not. Growth is prevented by inhibiting peptidoglycan synthesis. Thus these antibiotics only work for actively growing bacteria. The cell wall of new bacteria that grew in the presence of cell-wall-synthesis inhibitors is deprived of peptidoglycan. These bacteria will be subjected to osmotic lysis.In addition, gram-negative bacteria generally are less susceptible to inhibitors of cell wall synthesis than are gram-positive bacteria. In the former cell wall synthesis inhibitors fail to reach the cell wall because they are blocked by the gram-negative outer membrane.Penicillin is the classic example of an inhibitor of cell wall synthesis. Other examples include: ampicillin, bacitracin, carbapenems, cephalosporin, methicillin, oxacillin and vancomycin
12.COMPREHENSIVE OFANTIMICROBIAL AGENTS AND CHEMOTHERAPY ( CLASSIFICATION AND...Saminathan Kayarohanam
Antimicrobial Agents and Chemotherapy (AAC) features interdisciplinary studies that build our understanding of the underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy.
A protein synthesis inhibitor is a substance that stops or slows the growth or proliferation of cells by disrupting the processes that lead directly to the generation of new proteins. All of the antibiotics that target bacterial protein synthesis do so by interacting with the bacterial ribosome and inhibiting its function. The ribosome might not seem like a very good target for selective toxicity, because all cells, including our own, use ribosomes for protein synthesis.The good thing is that bacteria and eukaryotes have ribosomes that are structurally different. Bacteria have so-called 70S ribosomes and eukaryotes have 80S ribosomes. No, not '70s and '80s ribosomes, although that would be pretty entertaining. The S stands for 'Svedberg unit,' and it refers to the rate at which particles sediment down into the tube during high-speed ultracentrifugation. Basically, it tells us about the ribosome's molecular weight and shape.
70S and 80S ribosomes are different enough that antibiotics can specifically target one and not the other. Let's take a closer look at the bacterial 70S ribosome and see where some different kinds of antibiotics act on it. Remember that ribosomes are made of RNA and protein and that they have two subunits, one large and one small.
The bacterial 70S ribosome's subunits are the 50S subunit and the 30S subunit. Yes, I know, 50 + 30 = 80, not 70, but this is not a math mistake. Using the Svedberg unit to measure ribosomes means that things don't always add up perfectly, because rates of sedimentation are not additive like molecular weights are.
Before we get into the specifics of how antibiotics inhibit bacterial ribosomes, let's briefly review how ribosomes work. First, a tRNA loaded with a particular amino acid enters the ribosome at the A site. The tRNA's anticodon has to match the codon, or group of three nucleotides on the mRNA. Then, at the P site of the ribosome, a peptide bond forms between the previous amino acid and the new amino acid. Finally, the empty tRNA exits at the E site. This process repeats for the whole length of the mRNA, and the polypeptide chain continues to grow.
Myself Gaurav Chaudhary, Assistant Professor, I.T.S. College of Pharmacy.
The Slideshare contains complete Notes of Unit-1 Medicinal Chemistry-III BP601T
It contains the Classification, stereochemistry chemical degradation, and Structure-activity relationship of Antibiotics(Penicillin, Cephalosporins, Monobactum, Aminoglycosides).
The study material is authentic.
Bacteria have their own enzymes for
1. Cell wall formation
2. Protein synthesis
3. DNA replication
4. RNA synthesis
5. Synthesis of essential metabolites
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
2. 2
NUM CONTENT SLIDE
I DEFINITIONS 4
II HISTORY 7
III MECHANISMS OF ANTIMICROBIAL AGENTS 9
IV MECHANISMS OF ANTIBACTERIAL RESISTANCE 17
V GENERAL PRINCIPLES OF ANTI-INFECTIVE THERAPY 28
VI IDEAL ANTIMICROBIAL DRUG 29
VII PREVENTION OF ANTIBIOTIC RESISTANCE 30
2
3. 3
3
LEARNING OUTCOME
1. Able to understand and describe about antibiotics.
2. Understand the history of some antibiotics.
3. Abele to demonstrate the various mechanism of antibiotics.
4. Able to describe the antibiotic resistance mechanism and the
types of resistance
5. Able to understand the principles of antibiotic therapy.
6. To gain the knowledge of ideal antimicrobial drug therapy.
7. Able to describe and demonstrate, how to prevent the
antibiotic resistance.
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
4. 4
I.DEFINITIONS
Chemotherapy is the drug treatment for the
diseases caused by pathologic microorganisms,
parasites, and tumour cells.
“Chemical substance used to kill the
microorganism and cancer cell”
The objective of chemotherapy is to study and to
apply the drugs that have highly selective toxicity to
the pathogenic microorganisms and have no or less
toxicity to the host.
CON ...
4 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
5. 5
WHAT IS AN ANTIBIOTIC?
“Antibiotic” is from antibiosis, meaning against life.
“Substances produced by various species of microorganisms
(bacteria, fungi, actinomycetes) to kill or suppress the growth of
other microorganisms”
The minimal inhibitory concentration (MIC)
the minimum amount of a drug required to inhibit the growth of
bacteria in vitro.
• The minimal bactericidal concentration (MBC)
the minimum amount of a drug required to kill bacteria in vitro.
TYPE
Natural Antibiotics Antimicrobial drugs produced by microorganisms.
Synthetic Antibiotics Antimicrobial drugs
synthesized in the lab. CON ...
5 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
6. 6
Antimicrobial spectrum : the scope that
a drug kills or suppresses the growth of
microorganisms.
Narrow-spectrum: The drugs that only act
on one kind or one strain of bacteria.
(isoniazid )
Broad-spectrum: The drugs that have a
wide antimicrobial scope. (tetracycline,
chloramphenicol )
CON ...
6 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
7. II.HISTORY
7
1929 Penicillin discovered by
Alexander Fleming
Messy lab, cool damp weather, luck
1940 Florey and Chain mass produce
penicillin for war time use, becomes
available to the public.
1935 Sulfa drugs discovered
1943 Streptomycin discovered
Western civilization fundamentally changed
7
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
9. 9
III. MECHANISMS OF ANTIMICROBIAL AGENTS
1.INHIBITION OF CELL WALL SYNTHESIS
2.INHIBITION OF FUNCTIONS OF CELLULAR MEMBRANE
3. INHIBITION OF PROTEIN SYNTHESIS
4.INHIBITION OF NUCLEIC ACID SYNTHESIS
5.INHIBITION OF FOLIC ACID SYNTHESIS
CON ...
9
BACTERIAL CELL STRUCTURE
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
12. 12
1. Inhibition of cell wall synthesis
– Penicillins and cephalosporins stop synthesis
of wall by preventing cross linking of
peptidoglycan units.
– Bacitracin and vancomycin also interfere
here.
– Excellent selective toxicity
CON ...
12 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
13. 13
2. Inhibition of functions of cellular
membrane:
– The bacterial cell membrane is also called
cytoplasmic membrane. Its main compounds
are proteins and lipids.
– Polymyxins can selectively combine with
phosphatide in the cell membrane and cause
the increase of membranous permeability. As
the result, some important materials will
outflow from bacterial cells and result in
death of bacteria. CON ...
13 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
14. 14
3. Inhibition of protein synthesis
– Due to differences in ribosomes
– Eucaryotic cells have 80S (60S + 40S subunits)
ribosomes.
– Procaryotic cells have 70S (50S + 30S subunits)
ribosomes.
– Examples:
• Chloramphenicol,Macrolides and Clindamycin
bind to the 50S subunit.
• Tetracyclines and Aminoglycosides bind to
the 30S subunit.
CON ...
14 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
15. 15
4. Inhibition of nucleic acid synthesis
– Stop DNA replication
• Example: Quinolones-inhibiting DNA
gyrase; Metronidazole???-DNA
Polymerase
– Or stop RNA synthesis
• Example: Rifampin -binds to the bacterial
DNA-dependent RNA polymerase.
CON ...
15 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
16. 16
5. Inhibition of folic acid synthesis
A drug mimics a normal metabolite and
acts as a competitive inhibitor.
– Enzyme of cell recognizes the drug instead of
the normal metabolite-Pathway stops.
– Example: Sulfonamides and trimethoprim are
similar to PABA (para aminobenzoic acid).
inhibit folic acid synthesis by blocking
dihydrofolic acid synthase and reductase
respectively. CON ...
16 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
17. 17
IV.RESISTANCE TO ANTIBACTERIAL AGENTS
• Drug resistance is the phenomenon that
susceptibility of pathogenic microorganisms
to drugs becomes lower or even loses after
the microorganisms contact with drugs many
times.
• When the bacteria show resistance to one
drug, they are also resistant to some other
drugs. This phenomenon is called cross
drug resistance. CON ...
17 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
18. 18
MECHANISMS OF ANTIBACTERIAL RESISTANCE
1.Inhibition of drug uptake or blocking the
entry (Change their cell membrane and cell
wall permeability to the drug)
2. Produce enzymes that destroy the chemical
structures of drugs
3.Alter or modified the target molecule.
4. Activation of drug efflux pump.
18 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
21. 21
1. Mechanisms of antibacterial resistance
Structurally modified antibiotic target site,
resulting in:
– For example, as the receptor protein on the
30s ribosomal subunit may be deleted or
altered as a result of mutation, some
aminoglycosides cannot combine with the
bacteria.
CON ...
21 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
23. 23
3.Mechanisms of antibacterial resistance
Develop an altered metabolic pathway
– Bacteria can develop an altered metabolic
pathway that bypasses the reaction inhibited
by drugs.
– For example, sulfonamide resistance my
occur as a result of mutations that cause
over-production of PABA or cause production
of a folic acid-synthesizing enzyme that has
low affinity for sulfonamides.
Mechanisms of antibacterial resistance
PABA, p-aminobenzoic acid
23 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
24. 24
4. Mechanisms of antibacterial resistance
Altered uptake of antibiotics, resulting in:
– decreased permeability
– increased efflux
– For example, gram-negative bacillus can
induce some special proteins to block porin
channels in cell wall and prevent tetracyclines
into the bacillus.
CON ...
24 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
25. 25
A) TRANSFERMATION
When naked DNA (Antibiotic-resistance Gene) is released on
lysis of an organism and is taken up by another organism.
B) TRANSDUCTION
Antibiotic-resistance genes are transferred from one bacterium
to another by means of bacteriophages.
C) CONJUGATION
Direct contact between two bacteria:
Plasmids form a mating bridge across the bacteria and DNA is
exchanged, which can result in acquisition of antibiotic-
resistance genes by the recipient cell. Transposons can also
carry antibiotic-resistance genes
GENETIC TRANSFER
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
27. COMMON ANTIMICROBIALS AND METHODS OF
RESISTANCE
ANTIBIOTIC
METHOD OF
RESISTANCE
27
Tetracycline
B-Lactams
Sulfonamides
Fluoroquinolones
Aminoglycosides
Active efflux from cell
Hydrolysis or protein
binding
Overproduction of
antibiotic target
Modification of
antibiotics binding site
Enzymatic modification
antimicrobial
27Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
28. 28
V. GENERAL PRINCIPLES OF ANTI-INFECTIVE
THERAPY
Selection of an appropriate anti-infective agent
① Identification of the infecting organism should
precede antimicrobial therapy when possible.
② The pathogenic microorganism susceptibility to
antimicrobial agents should be determined, if a
suitable test exists.
③ Factors that influence the choice of an
antiinfective agent or its dosage for a patient
include the age, renal and hepatic function,
pregnancy status, and the site of infection, etc.
28 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
29. 29
VI. IDEAL ANTIMICROBIAL DRUG
Have highly selective toxicity to the pathogenic
microorganisms in host body
Have no or less toxicity to the host.
Low propensity for development of resistance.
Not induce hypersensitive in the host.
Have rapid and extensive tissue distribution
Be free of interactions with other drugs.
Be relatively inexpensive29 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
30. 30
VII. PREVENTION OF ANTIBIOTIC RESISTANCE
Patients :
•Take antibiotics exactly as the doctor prescribes.
•Do not skip doses.
•Complete the prescribed course, even when you feeling better.
•Only take antibiotics prescribed for you.
•Do not save antibiotics for the next illness.
•Discard any leftover medication once the treatment is completed.
•Do not ask for antibiotics to your doctor.
•Prevent infections by practicing hygiene and recommended vaccines.
Health professionals:
•Do not treat viral infections with antibiotics.
•Prescribe antibiotics only when they are absolutely necessary –
giving them at the right dose and only for as long as they are needed.
•Avoid unnecessary overlaps in antibiotics.
•Become familiar with resistance trends in your region. END
30 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
31. 31
“A drug is a chemical substance that has known
biological effects on humans or other animals”
DRUG IS THE CHEMICAL SUBSTANCE AND USED TODRUG IS THE CHEMICAL SUBSTANCE AND USED TO
1.PRIVANT DISEASE1.PRIVANT DISEASE ( vaccine)( vaccine)
2.IDENTIFIED DISEASE2.IDENTIFIED DISEASE (diagnostic kit)(diagnostic kit)
3. REDUCE/SUPPRESS DISEASE3. REDUCE/SUPPRESS DISEASE (pain killer)(pain killer)
4. CURE DISEASE4. CURE DISEASE ( kill the microbes)( kill the microbes)
5. CHANGE THE PSYCHOLOGY MOOD5. CHANGE THE PSYCHOLOGY MOOD
(sleeping tablets)(sleeping tablets)
DRUG
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
34. 34
Sir Alexander Fleming, FRSE, FRS,
FRCS was a Scottish biologist,
pharmacologist and botanist. He
wrote many articles on
bacteriology, immunology, and
chemotherapy.
Born: August 6, 1881, Lochfield
Died: March 11, 1955,
London, United Kingdom
Education:
St Mary's Hospital Medical School
(1903–1906),
Awards:
Nobel Prize in Physiology or Medicine
, John Scott Legacy Medal and
Premium
Children: Robert FlemingDr.K.Saminathan.M.Pharm, M.B.A, Ph.D